Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Biotech/Pharma - Alliances
ISA Pharmaceuticals Signs R&D Agreement With Shin Nippon Biomedical Laboratories 3/3/2015 2:31:22 PM
New Projects For Image Interpretation And Management In Clinical Trials Totaling €1.53M For MEDIAN Technologies 3/3/2015 10:19:06 AM
Exostar & DocuSign Partner to Help Life Sciences and Healthcare Organizations Go 100% Digital 3/3/2015 11:07:22 AM
Blueprint Medicines Strikes $265 Million Deal With Alexion Pharmaceuticals Inc. (ALXN) 3/3/2015 7:26:15 AM
Cerulean Pharma Inc. (CERU) Establishes Clinical Collaboration With The GOG Foundation To Study CRLX101 In Combination With Weekly Paclitaxel In Relapsed Ovarian Cancer 3/3/2015 9:03:38 AM
Regenicin (RGIN) Receives $2.3 Million In Final Payment From Amarantus 3/3/2015 8:57:31 AM
Genedata Biologics Licensed By Pfizer (PFE) 3/3/2015 8:44:00 AM
Fidelta Achieves Milestone In Collaboration With LEO Pharma 3/3/2015 8:11:05 AM
Islet Sciences Enters Into Exclusive License Agreement For Phase 2 SGLT2 Inhibitor Remogliflozin Etabonate 3/3/2015 7:47:03 AM
Pulmokine Receives $1 Million Investment From Broadview Ventures To Advance PAH Candidate Into First Clinical Trial 3/3/2015 7:45:51 AM
VWR, Inc. Announces Expansion Of Distribution Agreement With New England Biolabs, Inc. 3/3/2015 7:28:27 AM
New Jersey Startup Celimmune Aims to Give New Life to Shelved Amgen (AMGN) Drug 3/2/2015 6:31:48 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $15 Million From GlaxoSmithKline (GSK) for Advancing ISIS-TTR Rx 3/2/2015 7:04:21 AM
Crohn's and Colitis Foundation of America Release: Three Research Leaders Join Forces To Study Diet's Role In Inflammatory Bowel Diseases 3/2/2015 6:44:20 AM
PharMerica Announces Wholesale Drug Distribution Agreement With Cardinal Health (CAH) 3/2/2015 11:23:54 AM